| Patent application number | Description | Published |
|---|
| 20100047742 | TUBULE-BLOCKING SILICA MATERIALS FOR DENTIFRICES - Precipitated silica materials are provided for utilization as abrasives or thickeners within dentifrice formulations that simultaneously effectuate tubule blocking within tooth dentin to reduce dentin sensitivity. Such precipitated silica materials have sufficiently small particle sizes and exhibit certain ionic charge levels by, for example, adjusting the zeta potential properties of the precipitated silica materials through treatment with certain metals to permit effective static attraction and eventual accumulation within dentin tubules when applied to teeth from a dentifrice formulation. | 02-25-2010 |
| 20100189663 | MOUTH RINSE COMPOSITIONS INCLUDING CHEMICALLY MODIFIED SILICA OR SILICATE MATERIALS FOR SUSTAINED DELIVERY TO TOOTH SURFACES - Novel mouth rinse (i.e., mouthwash) compositions that permit delivery of silica or silicate materials to the surface of teeth through common mouth rinsing procedures are provided. Such compositions must exhibit proper suspension of the silica or silicate materials (in particulate form) to prevent settling during storage while simultaneously providing proper mouth rinsing properties. Such silica or silicate materials may themselves exhibit any number of therapeutic or aesthetic benefits as long as such materials are easily transferred through mouth rinsing and exhibit proper affinity for deposit on target teeth upon contact therewith. Such silica or silicate materials should exhibit, in one embodiment, certain ionic charge levels as well as sufficiently small particle sizes to permit effective static attraction and eventual accumulation on target tooth surfaces. Methods of utilizing such mouthwashes for breath freshening and/or cleaning, as well as silica or silicate material tooth accumulation, are encompassed within this invention as well. | 07-29-2010 |
| 20110206746 | CONTINUOUS SILICA PRODUCTION PROCESS AND SILICA PRODUCT PREPARED FROM SAME - Disclosed herein is a continuous process for preparing a silica product, comprising: (a) continuously feeding an acidulating agent and an alkali metal silicate into a loop reaction zone comprising a stream of liquid medium; wherein at least a portion of the acidulating agent and the alkali metal silicate react to form a silica product in the liquid medium of the loop reaction zone; (b) continuously recirculating the liquid medium through the loop reaction zone; and (c) continuously discharging from the loop reaction zone a portion of the liquid medium comprising the silica product. Silica products and dentifrice compositions comprising the silica products are also disclosed. A continuous loop reactor is also disclosed. | 08-25-2011 |
| 20110206749 | SILICA MATERIALS FOR REDUCING ORAL MALADOR - Disclosed herein are silica materials comprising an adduct on at least a portion of a surface thereof. The silica materials are capable of binding volatile sulfur compounds (VSC)s and thereby reducing oral malodor. Also disclosed are dentifrice compositions, oral care compositions comprising the silica materials, and methods of making and using the silica materials. | 08-25-2011 |
| Patent application number | Description | Published |
|---|
| 20090022774 | Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances for treatment of vascular disorder - A medical device comprising a supporting structure capable of containing or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient may contain one or more therapeutic agents or substances, with the carrier preferably including a coating on the surface thereof, and the coating containing the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. Drugs that are suitable for use in this invention include, but are not limited to, | 01-22-2009 |
| 20090047323 | Medical Devices Containing Rapamycin Analogs - A medical device comprising a supporting structure capable of containing or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient may contain one or more therapeutic agents or substances, with the carrier preferably including a coating on the surface thereof, and the coating containing the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. Drugs that are suitable for use in this invention include, but are not limited to Formula (I). This drug can be used in combination with another drug including those selected from anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these drugs. | 02-19-2009 |
| 20090047324 | Medical Devices Containing Rapamycin Analogs - A medical device comprising a supporting structure capable of containing or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient may contain one or more therapeutic agents or substances, with the carrier preferably including a coating on the surface thereof, and the coating containing the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. Drugs that are suitable for use in this invention include, but are not limited to Formula (I). This drug can be used in combination with another drug including those selected from anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these drugs. | 02-19-2009 |
